Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cryoablation vs Radiotherapy for Stage III Prostate Cancer
NCT02605226Unknown
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Start
- Nov 2015
- Primary completion
- Dec 2017
- Countries
- 1
01
Overview
Randomised, open-label trial in prostate cancer (PCa) (2 arms), sponsored by Tianjin Medical University Cancer Institute and Hospital. Primary endpoints: Median PSA progression-free survival at 12 months and Quality of Life impact at 12 months. Status: unknown.
02
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02605226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02605226.